External validation and recalibration of office- and laboratory-based cardiovascular risk scores for prediction of 10-year risk of fatal cardiovascular disease in 112,262 adults in Mexico City
Perezalonso-Espinosa, J.; Ramirez-Garcia, D.; Diaz-Sanchez, J. P.; Fermin-Martinez, C. A.; Carrillo-Herrera, K. B.; Cabrera-Quintana, L. A.; Davila-Lopez, G.; Malagon-Liceaga, A.; Basile-Alvarez, M. R.; Berumen-Campos, J.; Kuri-Morales, P.; Tapia-Conyer, R.; Alegre-Diaz, J.; Seiglie, J. A.; Antonio-Villa, N. E.; Bello-Chavolla, O. Y.
Show abstract
BACKGROUNDCardiovascular disease (CVD) is the leading cause of mortality in Latin America, yet most CVD risk prediction models were developed in high-income countries with limited validations in these settings. OBJECTIVESTo externally validate CVD risk prediction models for 10-year fatal CVD, and recalibrate the Globorisk-fatal model in Mexican population. METHODSWe analyzed 112,262 adults [≥]40 years from the Mexico City Prospective Study. Outcomes were restricted to fatal CVD, including myocardial infarction (MI) and stroke, censored at 10 years. CVD risk was estimated using the laboratory- and office-based Framingham, Globorisk, Globorisk-LAC, WHO, and SCORE2 equations. Discrimination was assessed with Harrells c-statistic and AUROCs, calibration with mean estimates, slopes, and calibration curves, and overall performance with Brier scores. Sex-specific recalibration of the Globorisk-fatal model was performed using observed 10-year risks. RESULTSDuring 10 years of follow-up, 2,429 fatal CVD events were recorded (1,667 MI, 762 stroke). All models showed good discrimination, with c-statistics ranging from 0.761-0.805 in men and 0.797-0.831 in women. The Globorisk-fatal model had the highest c-statistic in women (0.831, 95%CI 0.821-0.841), and the laboratory-based WHO-MI model in men (0.805, 95%CI 0.783-0.827). Despite this, all equations consistently overestimated CVD risk, particularly in women. Calibration analyses revealed systematic overprediction at higher risk levels, more pronounced in men. Recalibration of the Globorisk-fatal model improved agreement between predicted and observed risks, reducing overestimation. CONCLUSIONSCVD risk models showed good discrimination but consistently overestimated risk in this Mexican cohort. The recalibrated Globorisk-fatal model improves risk estimation of fatal CVD in Mexican adults.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Can machine learning improve risk prediction of incident hypertension? An internal method comparison and external validation of the Framingham risk model using HUNT Study data 93%
- Klotho plasma levels are an independent predictor of mortality in women with acute coronary syndrome 91%
- Opportunistic Assessment of Ischemic Heart Disease Risk Using Abdominopelvic Computed Tomography and Medical Record Data: a Multimodal Explainable Artificial Intelligence Approach 91%
Similar papers in this journal
- Estimation of Life’s Essential 8 Score with Incomplete Data of Individual Metrics 93%
- Development and validation of a cardiovascular diseases risk prediction model for Chinese males (CVDMCM) 93%
- Predicting long-term prognosis after percutaneous coronary intervention in patients with acute coronary syndromes: a prospective nested case-control analysis for county-level health services 92%
Similar papers in this journal
- Polygenic prediction of coronary heart disease among 130,000 Mexican adults 94%
- Metabolomics data improve 10-year cardiovascular risk prediction with the SCORE2 algorithm for the general population without cardiovascular disease or diabetes 94%
- Familial risk of myocardial infarction with non-obstructive and obstructive coronary arteries-A nation-wide cohort study 93%
Similar papers in this journal
- Development and validation of a risk prediction algorithm for high-risk populations combining genetic and conventional risk factors of cardiovascular disease 95%
- Longitudinal associations of sustained low or high income and income variability with incident cardiovascular disease in individuals with type 2 diabetes: a retrospective population-based cohort study 94%
- Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.